Abstract
Different dysglycemic states precede overt type 2 diabetes. Prediabetic dysglycemia also carries an increased cardiovascular risk per se. Prediabetic dysglycemia may be divided into impaired fasting glycemia, impaired glucose tolerance and intermediate hyperglycemia. Mixed forms of these are very common. Dysglycemia develops insidiously for many years and usually produces no symptoms until very late. It is possible to prevent prediabetic dysglycemia from progressing to manifest type 2 diabetes and it can also be made to return to normoglycemia. The importance of lifestyle interventions, pharmacological treatment, surgical treatment and community efforts are discussed.
Keywords: Prediabetic dysglycemia, insulin, impaired glucose tolerance, normoglycemia, dysmetabolic syndrome, cardiovascular risk
Current Diabetes Reviews
Title:Prediabetic Dysglycemia: Call for Action
Volume: 17 Issue: 1
Author(s): Åke Sjöholm*
Affiliation:
- Department of Internal Medicine, Division of Endocrinology and Diabetology, Gavle Hospital, SE-80324 Gavle,Sweden
Keywords: Prediabetic dysglycemia, insulin, impaired glucose tolerance, normoglycemia, dysmetabolic syndrome, cardiovascular risk
Abstract: Different dysglycemic states precede overt type 2 diabetes. Prediabetic dysglycemia also carries an increased cardiovascular risk per se. Prediabetic dysglycemia may be divided into impaired fasting glycemia, impaired glucose tolerance and intermediate hyperglycemia. Mixed forms of these are very common. Dysglycemia develops insidiously for many years and usually produces no symptoms until very late. It is possible to prevent prediabetic dysglycemia from progressing to manifest type 2 diabetes and it can also be made to return to normoglycemia. The importance of lifestyle interventions, pharmacological treatment, surgical treatment and community efforts are discussed.
Export Options
About this article
Cite this article as:
Sjöholm Åke *, Prediabetic Dysglycemia: Call for Action, Current Diabetes Reviews 2021; 17 (1) . https://dx.doi.org/10.2174/1573399816666200327161514
DOI https://dx.doi.org/10.2174/1573399816666200327161514 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Arterial Spin Labeling Perfusion MRI in Alzheimers Disease
Current Medical Imaging Sex-Genetic Interaction in the Risk for Cerebrovascular Disease
Current Medicinal Chemistry Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil)
Current Drug Delivery Multiple Defects in Energy Metabolism in Alzheimers Disease
Current Drug Targets Stroke as a Consequence of Sleep Apnea: Epidemiology, Pathophysiology and Treatment Strategies
Current Respiratory Medicine Reviews Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease
Mini-Reviews in Medicinal Chemistry Breaking the Barrier in Stroke: What Should we Know? A Mini-Review
Current Pharmaceutical Design Antiplatelet Therapy and Oral Anticoagulation for Prevention of Ischemic Stroke
Current Drug Therapy Is the Deficiency of Vitamin B12 Related to Oxidative Stress and Neurotoxicity in Parkinsons Patients?
CNS & Neurological Disorders - Drug Targets Interventions to Reduce Cardiovascular Risk in Children with Type 1 Diabetes
Current Diabetes Reviews Treatment-resistant Late-life Depression: Challenges and Perspectives
Current Neuropharmacology Methodologies to Assess Brain Drug Delivery in Lead Optimization
Current Topics in Medicinal Chemistry COVID19 - Far from Over: Call for Urgent Novel and Advanced Measures
Coronaviruses The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes
Current Genomics Encephalopathy: A Vicious Cascade Following Forebrain Ischemia and Hypoxia
Central Nervous System Agents in Medicinal Chemistry Impact of Cardiovascular Factors on Pulse Wave Velocity and Total Vascular Resistance in Different Age Group Patients with Cardiovascular Disorders
Current Aging Science Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application
Current Molecular Pharmacology Lipid-lowering Drug Therapy in Elderly Patients
Current Pharmaceutical Design Brain Adaptation to Stressful Stimuli: A New Perspective on Potential Therapeutic Approaches Based on BDNF and NMDA Receptors
CNS & Neurological Disorders - Drug Targets Relevance of the Vascular Effects of Insulin in the Rationale of its Therapeutical Use
Cardiovascular & Hematological Disorders-Drug Targets